FDA expands approved use of drug to include advanced lung cancer
September 2015 Drug Safety Labeling Changes includes 48 products with revisions to Prescribing Information
Enforcement Report for September 23, 2015
AAPM&R and ABPMR Release Joint Statement
US Compounding, Inc. Issues Voluntary Nationwide Recall of All Sterile Compounded Products
Avycaz (ceftazidime and avibactam): Drug Safety Communication - Dose Confusion and Medication Errors
Tramadol: Drug Safety Communication - FDA Evaluating Risks of Using in Children Aged 17 and Younger
Enforcement Report – September 9, 2015
September is National Pain Awareness Month
Congratulations to 2015 AAPM&R Award Recipients
Compounded Drugs Stored in Becton-Dickinson (BD) 3 ml and 5 ml Syringes
Prolotherapy with Phenol by Hartley Medical: Recall - Non-sterility Concern
July 2015 Safety Labeling Changes includes 49 products with revisions to Prescribing
Blue Square Market Issues Voluntary Nationwide Recall of Kaboom Action Strips and Lida Daidaihua Due to the Presence of Undeclared Sulfoaildenafil, Sibutramine and Phenolphthalein
Gilenya (fingolimod): Drug Safety Communication - FDA Warns About Cases of Rare Brain Infection
June 2015 Safety Labeling Changes – Banzel Inclusion
Non-aspirin Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Drug Safety Communication - FDA Strengthens Warning of Increased Chance of Heart Attack or Stroke
Sign Up for FREE Drug Recall Notifications and Patient Safety Alerts
Michael Lupinacci, MD, has joined U.S. Physiatry as Chief Medical Officer
AAPM&R Attends 2015 AMA Annual Meeting